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Introduction
Primary hepatocellular carcinoma (HCC) is usually fatal; 
fewer than 5% of  patients survive 5 years after diagnosis. 
The median survival is 4-6 months for patients with unre-
sectable tumors (1). For the past 15 years, TACE has served 
as a palliative option to extend the overall survival rate by 
66%, 47%, and 36.4% at 1, 2, and 3 years, respectively (2). 
TACE targets unresectable HCCs by delivering chemo-
therapeutic and embolic agents into the tumor to induce 
ischemia and necrosis. HCC chemoembolization is based 
on the fact that the normal liver parenchyma receives a 
dual blood supply from the hepatic artery and the portal 
vein, whereas HCCs are supplied exclusively by the hepatic 
artery (2). However, depending on the location (in conjunc-
tion with various other unknown factors), HCCs may occa-
sionally recruit and receive extrahepatic arterial supply. 
This makes pre-operative image planning an even more 
crucial step in achieving optimal results and favorable pa-
tient outcome. In some instances, these vessels themselves 
can extend to supply neighboring tissue or organs that are 
in close proximity, due either to exophytic tumor growth or 
extracapsular HCC infiltration to adjacent structures in 
close, direct contact with the liver. Nakai et al. have noted 
that, regardless of  tumor size, when HCCs are located in 
the ventral hepatic area directly beneath the diaphragm, 
the internal mammary artery can serve as a feeding vessel 
with hepatic artery occlusion caused by repeated TACE (3). 
Case report
A 76-year-old man with a past medical history significant 
for longstanding hypertension, cirrhosis, and HCC pre-
sented to physicians in 2005 for placement of  a peritoneal 
catheter for dialysis. Subsequently, he developed diffuse 
abdominal pain. A CT scan incidentally revealed a large, 
confluent mass located in the left lobe of  the liver measur-
ing 8.4 cm x 12.9 cm, with heterogeneous attenuation and 
hypodense areas (Fig. 1). Because of  the nonconfirmatory 
imaging and borderline alpha-fetoprotein and transami-
nase levels, a biopsy was initiated, which later confirmed 
the mass to be consistent with HCC. The patient was not a 
candidate for surgical resection because of  an already 
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compromised cirrhotic liver. Instead, the patient underwent 
chemoembolization and radiofrequency ablation, and the 
HCC initially responded to the treatments. However, de-
spite two aggressive TACE sessions, the mass continued to 
grow in size.
Given the frequent attempts at embolization procedures, 
and the hyperenhancement of  the tumor and its peripheral 
location, we suspected there might be an extrahepatic vas-
cular component supplying the HCC. Following an angio-
gram, the right internal mammary artery and superior 
epigastric artery were selectively catheterized via the right 
brachial artery approach (owing to the threat of  clot em-
bolization from pre-existing iliofemoral occlusive disease). 
Presurgical imaging did not show vascular connections 
from the superior epigastric artery to the right pulmonary 
artery. 
Arteriography after catheterization demonstrated a visi-
ble reflux of  contrast material into the distal portion of  the 
right-lower-lobe pulmonary artery, which could be attrib-
uted to the rerouting of  blood flow to accentuate the vascu-
lar connection that was difficult to detect in the pre-
operative arteriogram. Arteriography also showed GDA 
coils deployed, most likely during previous TACE attempts 
to block off  the gastro-omental artery feeding the HCC. 
However, it is difficult to know for sure because the patient 
received care at another facility before coming to our de-
partment (Fig. 2). Chemoembolization of  the HCC via the 
right-superior epigastric artery was performed using 
QuadraSphere (Biosphere Medical, South Jordan, Utah) 
embolic material mixed with doxorubicin, cisplatin, and 
mitomycin C. One-half  of  a vial of  100-300 micron Em-
bospheres (South Jordan, Utah) was injected until stasis to 
antegrade blood flow, and devascularization of  the hepatic 
tumor was achieved (Fig. 3). The patient tolerated the pro-
cedure well, was admitted for overnight observation, and 
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Figure 1. 76-year-old male with rare pulmonary infarction. 
Repeat CT scan of liver shows hyperenhanced mass (ar-
row) located in upper left lobe near the dome of the liver. 
Figure 2. 76-year-old male with rare pulmonary infarction. 
Hepatic angiogram reveals hypervascularity of the HCC 
and extrahepatic collateral feeder vessel (superior epigas-
tric artery, black arrow) supplying hepatic mass. Angiogram 
also reveals contrast filling in distal portion of pulmonary 
artery post-embolization (dotted black arrow). GDA coils are 
also seen from prior TACE operations (white arrow).
Figure 3. 76-year-old male with rare pulmonary infarction. 
Following embolic injection of microspheres, hepatic angio-
gram shows diminished antegrade flow and reduced vascu-
lar filling (dotted arrows).
was discharged the next day as per standard hospital 
protocol. 
Approximately three weeks following the TACE proce-
dure, the patient presented to the emergency department 
complaining of  low-grade fever, yellowish-productive spu-
tum, coughing, chest discomfort, tachypnea, and general-
ized pain. Laboratory results revealed a normal white-
blood-cell count of  5.5 cells/mL, hemoglobin of  9.8 g/dL, 
platelet count of  137,000, and glucose of  198 mg/dL. 
Chest X-ray revealed a round, opaque mass located in the 
right-lower-lung zone (Fig. 4). The patient was admitted to 
the hospital and immediately started on intravenous antibi-
otics. A chest CT scan confirmed the same findings as the 
chest X-ray, revealing a wedge-shaped hyperdense mass in 
the right-lower lobe that was consistent with pulmonary 
infarction (Fig. 5). Pulmonary embolism was ruled out as 
the cause of  the infarction. The remainder of  the hospital 
stay was uneventful. The patient responded well to the in-
travenous antibiotics and was discharged several days later 
in stable condition. A chest CT scan was repeated three 
months later, which showed a substantial resolution of  the 
lobar infarct (Fig. 6). 
Discussion
The superior epigastric artery originates from the inter-
nal mammary artery, at the level of  the sixth intercostal 
space. This artery gives off  some branches to the dia-
phragm; they extend into the falciform ligament of  the 
liver and anastomose with the hepatic artery. Attempts to 
selectively catheterize and embolize extrahepatic collateral 
feeding vessels supplying HCCs remain a constant chal-
lenge for clinicians. According to Cheng et al., the most 
common extrahepatic collateral arterial supply of  HCC 
involves the inferior phrenic artery and the omental arteries 
that arise from the gastroduodenal artery and, in some 
cases, the splenic artery. However, considering the close 
proximity of  the liver and the diaphragm and the broad 
contact between them, it may be expected that diaphrag-
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Figure 4. 76-year-old male with rare pulmonary infarction. 
Chest X-ray image shows right lower lobar consolidation 
with hypervascular lung markings. The opaque mass (blue 
arrow) is clearly visible, with the distribution consistent with 
the lower lung zone.
Figure 6. 76-year-old male with rare pulmonary infarction. 
Following treatment, CT scan 3 months later shows signifi-
cant resolution of infarcted lung tissue (arrow).
Figure 5. 76-year-old male with rare pulmonary infarction. 
Supplemental axial CT scan shows wedge-shaped infarct 
(arrow) that developed post-TACE. The distribution spans to 
the rib wall and pleura.
matic blood supplies, including the internal mammary and 
intercostal arteries, are also key sources of  collateral circula-
tion as well (4). It is important to recognize that not all such 
vessels can be safely treated without risk to other important 
organs. 
It is unclear whether this patient had a congenital expla-
nation for this abnormal vascular connection between the 
superior epigastric artery and the right-pulmonary artery, 
or whether this anatomy could be explained away by vascu-
lar endothelial growth factors coaxed by the tumor. Never-
theless, these variations underscore the need for thorough 
visceral arteriography before initial chemoembolization to 
reduce the chances of  nontarget embolization. It was also 
inferred that the patient’s symptoms could be explained by 
rogue embolization (which is defined by embolic material 
unintentionally inhibiting blood supply to nontarget or-
gans), considering that the patient had no history of  pul-
monary disease or prior chest X-rays displaying the con-
solidation that was revealed at admission. Pre-operational 
imaging did not show vascular connections from the supe-
rior epigastric artery to the right pulmonary artery. Imag-
ing after arteriography demonstrated a visible reflux of  
contrast material into the distal portion of  the right-lower-
lobe pulmonary artery, which could be attributed to the re-
routing of  blood flow to accentuate the vascular connection 
that was difficult to detect during the pre-operative 
arteriogram. 
Some would speculate that symptoms directly related to 
intraprocedural reflux of  embolic material into the pulmo-
nary artery would present rapidly, within a couple of  days 
after the procedure had been done. However, one possible 
explanation for this patient’s delayed presentation might be 
that the pulmonary infarct was masked by the patient’s 
post-procedural pain medication, and the onset of  bacterial 
pneumonia added further insult, causing a breakthrough of 
symptoms three months later. 
This case report stresses some key points. First, thorough 
pre-operative imaging to detect any anatomic variations of  
parasitized tumor vessels is vital to assess the amount of  
risk for nontarget organ involvement. Although arteriog-
raphic studies are arguably suggestive at best, they can offer 
detailed imaging information that the interventionalist 
must carefully evaluate. Second, what is considered accept-
able risk when it comes to patient’s current disease status 
vs. the likelihood of  inadvertent nontarget organ damage 
has still yet to be defined. In cases where nontarget organ 
vascular supply is confirmed through imaging, perhaps the 
inclusion criteria of  super-selective catheterization of  these 
vessels (to avoid collateral organ damage) needs to be as-
sessed. Of  course, these options must be carefully weighed 
against the possible risk of  vessel spasm or rupture. Super-
selective catheterization is also limited by the diameter and 
tortuosity of  the involved vessel that allows a catheter to be 
placed (5). It is important for clinicians to keep in mind 
that, although pulmonary involvement is rare, complica-
tions associated with TACE should be recognized and ad-
dressed swiftly, to ensure patient safety and decrease 
hospitalization. 
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